Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Oakmark Fund International Small Cap 2026 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (Oakmark Fund International Small Cap)

Primary Source Intelligence • Q3 2026 Letter Analysis

Oakmark Fund International Small Cap Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Oakmark Fund International Small Cap. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+6.11%

YTD+2.19%

Annualized+8.76%

Positioning StanceCONSTRUCTIVE

Market CapSmallCap

GeographyEurope, Asia, Emerging markets

Digest Analysis

Quick Take

"Oakmark International Small Cap Fund returned 6.11% net in Q3 2026, driven by outperformance in industrials and health care holdings such as Hays, while deploying capital into newly initiated positions in Arcadis, DO & CO, and Verisure."

Executive Summary

Oakmark International Small Cap Fund (Investor Class) delivered a net return of 6.11% in the third quarter of 2026, advancing 2.19% net year-to-date and outperforming its benchmark, the MSCI World ex USA Small Cap Index, which gained 2.88% net during the quarter. Strong absolute and relative performance was led by holdings in the industrials and health care sectors, with Italy, the United Kingdom, and Finland serving as the primary geographic contributors. Top regional allocations remained concentrated in Europe ex-U.K. at 57.3%, Japan at 11.9%, the U.K. at 11.3%, and emerging markets at 11.1% of the portfolio. The investment team noted that persistent international economic headwinds, currency volatility, and geopolitical uncertainty continue to depress valuations across global small caps, creating fertile ground for fundamental value investing. The managers maintain that market participants are overreacting to cyclical and macro noise, allowing patient investors to purchase high-quality franchises characterized by oligopolistic market structures, recurring subscription revenues, and sustainable pricing power at steep discounts to intrinsic value. Portfolio turnover featured the initiation of new positions in engineering consultant Arcadis NV, premium airline caterer DO & CO, and residential security provider Verisure, capitalizing on post-IPO declines and transitory operational opacity. The fund completely liquidated its stakes in Alten, DTS, and Essentra, while top individual performance contributors included staffing specialist Hays, Valmet, and Adecco.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

68%

CautiousHigh

Moderate (68%)

Market Conviction

Oakmark demonstrates steady bottom-up conviction with disciplined position sizing, maintaining top individual holdings between 1.0% and 2.8% of assets. The team articulates detailed, multi-point investment rationales for new additions like Arcadis, DO & CO, and Verisure, though the strategy remains relatively diversified across global markets rather than hyper-concentrated.

65%

BearishBullish

Bullish (65%)

Growth Outlook

The managers view broader macroeconomic, geopolitical, and currency volatility constructively as an ideal catalyst creating attractive buying opportunities in international equities. While acknowledging ongoing global economic headwinds, they express clear optimism that patient investors will realize substantial returns as intrinsic value gaps close.

70%

DefensiveAggressive

Balanced (70%)

Risk Appetite

Positioning reflects a healthy risk tolerance through the initiation of cyclical and post-IPO turnarounds such as Arcadis and Verisure. Oakmark maintains minimal cash drag, deploying capital into out-of-favor international names and emerging market exposure at 11.1%.

65%

De-riskingDeploying

Net Neutral (65%)

Capital Deployment

Capital was actively recycled during the period, balancing three new position initiations (Arcadis, DO & CO, Verisure) against three complete position eliminations (Alten, DTS, Essentra). Net deployment indicates selective re-allocation rather than aggressive cash drawdown.

72%

CautiousExpansionary

Expansionary (72%)

Forward Guidance

The fund actively committed capital to three new small-cap holdings during the quarter while completely exiting three underperforming or mature positions. Commentary indicates an ongoing bias to accumulate high-conviction franchises suffering from temporary operational or geopolitical discounts.

74%

BearishBullish

Bullish (74%)

Language Signal

Tone is predominantly constructive, highlighting concepts such as 'attractive opportunities', 'discounts to intrinsic value', 'strong franchises', and 'free cash flow inflecting'. Macro risks like geopolitical unrest and currency swings are framed primarily as valuation entry catalysts.

58%

Low RiskElevated

Moderate Risk (58%)

Perceived Risk

The managers explicitly acknowledge elevated macro risks including currency fluctuations, regional geopolitical conflict in the Middle East, inflation in customer acquisition costs, and potential artificial intelligence disruption, but treat these as manageable operational factors.

68%

ScarceAbundant

Abundant (68%)

Opportunity Density

Management finds an appealing slate of selective opportunities across European and Asian small caps, evidenced by three new portfolio purchases. However, they emphasize the need for rigorous selectivity given uneven sector fundamentals and macroeconomic clouds.

75%

Short-TermLong-Term

Decade+ (75%)

Time Horizon

Oakmark repeatedly stresses a multi-year, long-term horizon, explicitly noting that patient capital is required to allow the gap between market prices and intrinsic business value to narrow over multi-year corporate investment cycles.